BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Pozen Licenses MT 300 Rights To Xcel In Deal Worth At Least $10M

Sep. 5, 2003
By Aaron Lorenzo

CAT Avoids Patent Fight, Enters Deal With Enzon And Micromet

Sep. 4, 2003
By Aaron Lorenzo

CAT Avoids Patent Fight, Enters Deal With Enzon And Micromet

Sep. 4, 2003
By Aaron Lorenzo

AVI Terminates Planned Buyout Of eXegenics As Offer Expires

Sep. 3, 2003
By Aaron Lorenzo
Another merger agreement has fallen apart for eXegenics Inc. For the second time in the past year, the Dallas-based company saw its plans dissolve about two months after initially reporting a decision to combine with another firm. The latest suitor to walk away, AVI BioPharma Inc., said an insufficient number of eXegenics shareholders agreed to the tender offer. (BioWorld Today)
Read More

AVI Terminates Planned Buyout Of eXegenics As Offer Expires

Sep. 3, 2003
By Aaron Lorenzo
Another merger agreement has fallen apart for eXegenics Inc. For the second time in the past year, the Dallas-based company saw its plans dissolve about two months after initially reporting a decision to combine with another firm. The latest suitor to walk away, AVI BioPharma Inc., said an insufficient number of eXegenics shareholders agreed to the tender offer. (BioWorld Today)
Read More

Explosions Hit Chiron In Wake Of Recent Animal Rights Protests

Sep. 2, 2003
By Aaron Lorenzo
Chiron Corp. was bombed last week in what may have been the latest and most violent offense in a string of harassment incidents brought by animal rights protesters. (BioWorld Today)
Read More

Explosions Hit Chiron In Wake Of Recent Animal Rights Protests

Sep. 2, 2003
By Aaron Lorenzo
Chiron Corp. was bombed last week in what may have been the latest and most violent offense in a string of harassment incidents brought by animal rights protesters. (BioWorld Today)
Read More

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Aug. 29, 2003
By Aaron Lorenzo

Berlex Planning Phase III Study Of Leukine In Crohn's Patients

Aug. 29, 2003
By Aaron Lorenzo

Nymox Raises $12M Privately To Provide Three Years' Cash

Aug. 28, 2003
By Aaron Lorenzo
Previous 1 2 … 174 175 176 177 178 179 180 181 182 … 237 238 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing